Jazz Pharmaceuticals (JAZZ) Earnings Date, Estimates & Call Transcripts → Will this $2 AI stock double overnight? (From Behind the Markets) (Ad) Free JAZZ Stock Alerts $108.32 -1.35 (-1.23%) (As of 04/24/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 1After Market ClosesConfirmedActual EPS (Feb. 28) $4.40 Missed By -$0.04 Consensus EPS (Feb. 28) $4.44 Read Call TranscriptListen to Call Get Jazz Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueJAZZ Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.JAZZ Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsWill this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!Click here to learn more >>> Jazz Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$3.24$3.60$3.42 Q2 20242$3.68$4.23$3.96 Q3 20242$3.95$4.52$4.24 Q4 20241$4.17$4.17$4.17 FY 20247$15.04$16.52$15.78 Q1 20251$3.64$3.64$3.64 Q2 20251$3.89$3.89$3.89 Q3 20251$4.06$4.06$4.06 Q4 20251$4.31$4.31$4.31 FY 20254$15.90$15.90 $15.90JAZZ Earnings Date and InformationJazz Pharmaceuticals last released its earnings results on February 28th, 2024. The specialty pharmaceutical company reported $4.40 EPS for the quarter, missing the consensus estimate of $4.44 by $0.04. The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1.01 billion. Jazz Pharmaceuticals has generated $6.12 earnings per share over the last year ($6.12 diluted earnings per share) and currently has a price-to-earnings ratio of 17.7. Earnings for Jazz Pharmaceuticals are expected to grow by 14.72% in the coming year, from $16.24 to $18.63 per share. Jazz Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Wednesday, May 1st, 2024. Jazz Pharmaceuticals will be holding an earnings conference call on Wednesday, May 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call.. Read More Jazz Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/1/2024Confirmed)------- 2/28/2024Q4 2023$4.44$4.40($0.04)$7.38$1.01 billion$1.01 billion 11/8/2023Q3 2023$4.21$4.22+$0.01$6.30$969.47 million$972.14 million8/9/2023Q2 2023$3.68$3.83+$0.15$6.14$952.44 million$957.32 million5/10/2023Q1 2023$3.58$3.20($0.38)$5.36$898.11 million$892.81 million3/1/2023Q4 2022-($0.84)($0.84)$2.14$972.70 million$972.12 million11/9/2022Q3 2022$4.35$4.53+$0.18$9.37$939.88 million$940.65 million Get the Latest News and Ratings for JAZZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jazz Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/3/2022Q2 2022$3.63$3.62($0.01)$6.69$908.23 million$932.88 million5/4/2022Q1 2022$3.00$3.13+$0.13$6.23$853.73 million$813.72 million 3/1/2022Q4 2021$2.98$3.66+$0.68$7.89$866.71 million$896.73 million 11/9/2021Q3 2021$2.60$4.20+$1.60$8.14$829.98 million$838.12 million 8/3/2021Q2 2021$3.08$3.90+$0.82$12.69$743.19 million$751.81 million 5/4/2021Q1 2021$3.09$3.92+$0.83$4.75$613.07 million$607.58 million Jazz Pharmaceuticals Earnings - Frequently Asked Questions When is Jazz Pharmaceuticals's earnings date? Jazz Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Wednesday, May 1st, 2024. Learn more on JAZZ's earnings history. Did Jazz Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Jazz Pharmaceuticals (NASDAQ:JAZZ) missed the analysts' consensus estimate of $4.44 by $0.04 with a reported earnings per share (EPS) of $4.40. Learn more on analysts' earnings estimate vs. JAZZ's actual earnings. How can I listen to Jazz Pharmaceuticals's earnings conference call? The conference call for Jazz Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Jazz Pharmaceuticals's conference call transcript? The conference call transcript for Jazz Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Jazz Pharmaceuticals generate each year? Jazz Pharmaceuticals (NASDAQ:JAZZ) has a recorded annual revenue of $3.83 billion. How much profit does Jazz Pharmaceuticals generate each year? Jazz Pharmaceuticals (NASDAQ:JAZZ) has a recorded net income of $414.83 million. JAZZ has generated $6.12 earnings per share over the last four quarters. What is Jazz Pharmaceuticals's price-to-earnings ratio? Jazz Pharmaceuticals (NASDAQ:JAZZ) has a trailing price-to-earnings ratio of 17.70 and a forward price-to-earnings ratio of 6.67. The price/earnings-to-growth ratio is 1.5. What is Jazz Pharmaceuticals's EPS forecast for next year? Jazz Pharmaceuticals's earnings are expected to grow from $16.24 per share to $18.63 per share in the next year, which is a 14.72% increase. More Earnings Resources from MarketBeat Related Companies: MRTX Earnings PRGO Earnings CORT Earnings ELAN Earnings CYTK Earnings APLS Earnings VKTX Earnings CERE Earnings IONS Earnings ITCI Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:JAZZ) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
